Memantine protects against secondary neuronal degeneration in lateral geniculate nucleus and superior colliculus after retinal damage in mice

CNS Neuroscience and Therapeutics

Volumn 14, Issue 3, 2008, Pages 192-202

  Ito, Yasushi ^a   Nakamura, Shinsuke ^a   Tanaka, Hirotaka ^a   Shimazawa, Masamitsu ^a   Araie, Makoto ^b   Hara, Hideaki ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Glaucoma; Memantine; Mouse; NMDA; Visual pathway

Indexed keywords

MEMANTINE; N METHYL DEXTRO ASPARTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; LATERAL GENICULATE NUCLEUS; MALE; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; RETINA GANGLION CELL; RETINA INJURY; SUPERIOR COLLICULUS; VITREOUS BODY;

ANIMALS; CELL DEATH; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; EXCITATORY AMINO ACID ANTAGONISTS; FOLLOW-UP STUDIES; GENICULATE BODIES; MALE; MEMANTINE; MICE; MICE, INBRED C57BL; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; RETINA; RETINAL DISEASES; RETINAL GANGLION CELLS; SUPERIOR COLLICULI; VISUAL PATHWAYS;

EID: 49749100096     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/j.1755-5949.2008.00050.x     Document Type: Article

References (35)

1. d-aspartate (NMDA) receptor antagonist - a review of preclinical data. Neuropharmacol 1999 38 : 735 767.
2. Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ. Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med 2003 348 : 1333 1341.
3. Hare WA, WoldeMussie E, Weinreb RN, Ton H, Ruiz G, Wijono M, Feldmann B, Zangwill L, Wheeler L. Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, II: Structural measures. Invest Ophthalmol Vis Sci 2004 45 : 2640 2651.
4. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol 1996 80 : 389 393.
5. Yücel YH, Gupta N, Zhang Q, Mizisin AP, Kalichman MW, Weinreb RN. Memantine protects neurons from shrinkage in the lateral geniculate nucleus in experimental glaucoma. Arch Ophthalmol 2006 124 : 217 225.
6. Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol 1996 114 : 299 305.
7. Honkanen RA, Baruah S, Zimmerman MB, Khanna CL, Weaver YK, Narkiewicz J, Waziri R, Gehrs KM, Weingeist TA, Boldt HC, Folk JC, Russell SR, Kwon YH. Vitreous amino acid concentrations in patients with glaucoma undergoing vitrectomy. Arch Ophthalmol 2003 121 : 183 188.
8. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994 330 : 613 622.
9. Osborne NN, Wood JP, Chidlow G, Bae JH, Melena J, Nash MS. Ganglion cell death in glaucoma: What do we really know? Br J Ophthalmol 1999 83 : 980 986.
10. d-aspartic acid suppresses Akt activity through protein phosphatase in retinal ganglion cells. Mol Vis 2005 11 : 1173 1182.
11. Yoneda S, Tanihara H, Kido N, Honda Y, Goto W, Hara H, Miyawaki N. Interleukin-1beta mediates ischemic injury in the rat retina. Exp Eye Res 2001 73 : 661 667.
12. Shimazawa M, Inokuchi Y, Ito Y, Murata H, Aihara M, Miura M, Araie M, Hara H. Involvement of ER stress in retinal cell death. Mol Vis 2007 13 : 578 587.
13. Suemori S, Shimazawa M, Kawase K, Satoh M, Nagase H, Yamamoto T, Hara H. Metallothionein, an endogenous antioxidant, protects against retinal neuron damage in mice. Invest Ophthalmol Vis Sci 2006 47 : 3975 3982.
14. Ito Y, Shimazawa M, Inokuchi Y, Fukumitsu H, Furukawa S, Araie M, Hara H. Degenerative alterations in the visual pathway after NMDA-induced retinal damage in mice. Brain Res 2008 1212 : 89 101.
15. Wang X, Sam-Wah Tay S, Ng YK. Nitric oxide, microglial activities and neuronal cell death in the lateral geniculate nucleus of glaucomatous rats. Brain Res 2000 878 : 136 147.
16. Yücel YH, Zhang Q, Gupta N, Kaufman PL, Weinreb RN. Loss of neurons in magnocellular and parvocellular layers of the lateral geniculate nucleus in glaucoma. Arch Ophthalmol 2000 118 : 378 384.
17. Quigley HA, Dunkelberger GR, Green WR. Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol 1989 107 : 453 464.
18. Gupta N, Ang LC, Noel de TL, Bidaisee L, Yücel YH. Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex. Br J Ophthalmol 2006 90 : 674 678.
19. Mooney SM, Miller MW. Postnatal generation of neurons in the ventrobasal nucleus of the rat thalamus. J Neurosci 2007 27 : 5023 5032.
20. d-aspartate (NMDA) receptor antagonist memantine in man. Neurosci Lett 1995 195 : 137 139.
21. Zajaczkowski W, Quack G, Danysz W. Infusion of (+)-MK-801 and memantine - contrasting effects on radial maze learning in rats with entorhinal cortex lesion. Eur J Pharmacol 1996 296 : 239 246.
22. Minkeviciene R, Banerjee P, Tanila H. Memantine improves spatial learning in a transgenic mouse model of Alzheimer's disease. J Pharmacol Exp Ther 2004 311 : 677 682.
23. Vorwerk CK, Lipton SA, Zurakowski D, Hyman BT, Sabel BA, Dreyer EB. Chronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine. Invest Ophthalmol Vis Sci 1996 37 : 1618 1624.
24. Harada T, Harada C, Nakamura K, Quah HM, Okumura A, Namekata K, Saeki T, Aihara M, Yoshida H, Mitani A, Tanaka K. The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. J Clin Invest 2007 117 : 1763 1770.
25. Grunert U, Haverkamp S, Fletcher EL, Wassle H. Synaptic distribution of ionotropic glutamate receptors in the inner plexiform layer of the primate retina. J Comp Neurol 2002 447 : 138 151.
26. Vrabec JP, Levin LA. The neurobiology of cell death in glaucoma. Eye 2007 21 (Suppl 1 S11 S14.
27. Finn JT, Weil M, Archer F, Siman R, Srinivasan A, Raff MC. Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases. J Neurosci 2000 20 : 1333 1341.
28. Jaubert-Miazza L, Green E, Lo FS, Bui K, Mills J, Guido W. Structural and functional composition of the developing retinogeniculate pathway in the mouse. Vis Neurosci 2005 22 : 661 676.
29. Jones EG, Tighilet B, Tran BV, Huntsman MM. Nucleus- and cell-specific expression of NMDA and non-NMDA receptor subunits in monkey thalamus. J Comp Neurol 1998 397 : 371 393.
30. Marvanova M, Lakso M, Pirhonen J, Nawa H, Wong G, Castren E. The neuroprotective agent memantine induces brain-derived neurotrophic factor and trkB receptor expression in rat brain. Mol Cell Neurosci 2001 18 : 247 258.
31. Meisner F, Scheller C, Kneitz S, Sopper S, Neuen-Jacob E, Riederer P, Meulen VT, Koutsilieri E. Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: A novel pharmacological action of memantine. Neuropsychopharmacology 2008 33 : 2228 2236.
32. Yücel YH, Yeung J, Weinreb RN, Kaufman PL, Gupta N. Alteration of nerve growth factor receptors TrkB and TrkC in the lateral geniculate nucleus. Paper presented at Annual Association for Research in Vision and Ophthalmology Meeting, May 4, Fort Lauderdale, FL, 2002.
33. Avwenagha O, Bird MM, Lieberman AR, Yan Q, Campbell G. Patterns of expression of brain-derived neurotrophic factor and tyrosine kinase B mRNAs and distribution and ultrastructural localization of their proteins in the visual pathway of the adult rat. Neuroscience 2006 140 : 913 928.
34. Hetman M, Kanning K, Cavanaugh JE, Xia Z. Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J Biol Chem 1999 274 : 22569 22580.
35. Nakazawa T, Tamai M, Mori N. Brain-derived neurotrophic factor prevents axotomized retinal ganglion cell death through MAPK and PI3K signaling pathways. Invest Ophthalmol Vis Sci 2002 43 : 3319 3326.